SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-017951
Filing Date
2023-05-12
Accepted
2023-05-12 17:02:10
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20230331.htm   iXBRL 10-Q 803834
2 EX-10.1 ajkazimiemploymentagreemen.htm EX-10.1 37287
3 EX-10.2 jameshermanemploymentagree.htm EX-10.2 34504
4 EX-10.3 toddanthony-employmentagre.htm EX-10.3 34401
5 EX-10.4 chrisbittermanemploymentag.htm EX-10.4 34414
6 EX-10.5 johnhammemploymentagreemen.htm EX-10.5 34345
7 EX-31.1 a2023q1-exhibit311.htm EX-31.1 12647
8 EX-31.2 a2023q1-exhibit312.htm EX-31.2 12641
9 EX-32.1 a2023q1-exhibit321.htm EX-32.1 6972
15 image_0.jpg GRAPHIC 39614
  Complete submission text file 0001628280-23-017951.txt   4331969

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20230331.xsd EX-101.SCH 32432
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20230331_cal.xml EX-101.CAL 51005
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20230331_def.xml EX-101.DEF 125127
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20230331_lab.xml EX-101.LAB 386484
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20230331_pre.xml EX-101.PRE 251786
56 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20230331_htm.xml XML 491931
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 23916855
SIC: 2834 Pharmaceutical Preparations